The anti-infective medicine sales in Canada are projected to decline slightly over the forecast period from 2024 to 2028. In 2023, the market stood at 5.4. However, forecasts indicate a decrease, with sales values going from 5.1 in 2024 to 4.8 in 2028. A constant year-on-year decline of approximately 2% is expected, showing a cautious trend within the market. The five-year CAGR suggests an average annual decrease, indicating a shrinking sector over the long term.
Future trends to watch for include advancements in bio-medicine and personalized treatments that may alter market demand. Keeping an eye on regulatory changes and innovations in drug development could influence future sales. Additionally, monitoring public health scenarios and antibiotic stewardship initiatives will be crucial in understanding market dynamics.
